38results about How to "Treatment applicable" patented technology

The present invention relates to alpha-type zinc- phthalocyanine nanowires (ZnPc NWs) having enhanced water solubility and water dispersibility, to a composite of an alpha-type zinc-phthalocyanine nanowire / phenothiazine, to a method for preparing same, and to a photosensitizer including same or a pharmaceutical composition including same for preventing or treating cancers. Since the alpha-type zinc-phthalocyanine nanowires or the composite of alpha-type zinc-phthalocyanine nanowire / phenothiazine according to the present invention exhibit dual traits, i.e., photothermal and photodynamic traits in single molecules, they are very useful for the development of a multifunctional molecular system and can also be usefully applied to light therapy of cancers due to their good light therapeutic effects. Also, the composite of alpha-type zinc-phthalocyanine nanowire / phenothiazine itself can exhibit fluorescence to facilitate the introduction of an imaging system, so that diagnosis and treatment can be simultaneously performed using a single substance.

The invention relates to a Chinese traditional medicine for treating cardiopathy, which comprises Chinese medicinal herbs including Chinese angelica root, Ligusticum wallichii, root of red rooted saliva, prepared rhizome of rehmannia, radix paeoniae rubrathe, red ginseng, white atractylodes rhizome, astragalus root, honey-fried licorice root, raw astragalus root, cimicifuga rhizome, schisandra fruit, Bupleurum root, medicated leaven, malt, rhizoma dioscoreae, motherwort, Cinnamomum cassia, cassia twig, asaryl, dodder seed, lilyturf root, prepared aconite root, dried ginger, aniseed, broomrape, safflower, epimeddium, grassleaved sweetflag rhizome, zanthoxylum piperitum, deer horn gum, notoginseng, and leeches.

The present invention relates to certain 2-(2,4,5-substituted anilino)pyrimidine compounds represented by the following formula I and applications thereof. These compounds or salts thereof show higher inhibition of EGFR in activated or drug-resistant mutant forms than in wild-type EGFR. Due to the reduced toxicity associated with wild-type EGFR inhibition, the compound or its salt is expected to have excellent pharmacodynamic properties, higher metabolic stability, better permeability of the blood-brain barrier, and is more suitable for use as a therapeutic agent, Especially suitable for the treatment of cancer. Therefore, these compounds or their salts can be used to prepare drugs for treating certain mutation forms of EGFR-mediated diseases, especially non-small cell lung cancer.

The invention provides a short peptide for antibacterial, antipruritic, anti-inflammatory, detumescence, and scar removal and application thereof. The amino acid main sequence of the short peptide fragments, analogs, derivatives, and variants of the short peptide has ≥70% identity and ≥90% similarity with the short peptide amino acid main sequence; short peptides, nucleotides, short Peptide fragments, short peptide analogs, short peptide derivatives and short peptide variants are used for the preparation of antibacterial, antipruritic, anti-inflammatory and detumescent drugs for various skin disinfection or treatment of skin diseases, for the preparation of neurodermatitis, contact dermatitis, chronic eczema , Drug application for topical treatment of insect bite dermatitis and pruritic skin diseases. The short peptide involved in the invention has a clear molecular structure, mature production technology, and the finished product is non-toxic, harmless, and has no side effects. Its remarkable feature is that it does not leave scars after being cured.

The invention relates to a traditional Chinese medicine composition for treating chronic glomerulonephritis and a preparation method thereof. The traditional Chinese medicinal composition is prepared from the following raw materials: rehmannia glutinosa, yam, wolfberry, dogwood meat, dodder, tortoise board glue, antlers Gum, Polyporus, Poria, Bupleurum, Atractylodes, Guizhi, Cicada slough, windproof, Rhizoma Imperatae, Achyranthes. The traditional Chinese medicine composition for treating chronic glomerulonephritis has a reasonable composition, can achieve the effect of tonifying both yin and yang of the kidney, and the effect of tonifying the kidney is stable and lasting. While fundamentally treating the loss of nephrons in chronic glomerulonephritis, it can also effectively relieve symptoms such as proteinuria, hematuria, and hypertension.

The invention discloses an olmesartan medoxomil / rosuvastatin compound preparation and a preparation method thereof. The olmesartan medoxomil / rosuvastatin compound preparation is characterized by being prepared from a main drug and auxiliary materials, wherein the main drug is prepared from olmesartan medoxomil and rosuvastatin; the auxiliary materials comprise filler, a disintegrating agent, an adhesive, lubricant and a flow aid; the olmesartan medoxomil / rosuvastatin compound preparation is prepared through the process steps of raw material selecting, preparation, mixing, soft material preparing, pelleting, drying, particle finishing, total blending, finished product forming and the like. Olmesartan medoxomil is an ARB antihypertensive drug, has approximately-ideal pharmacological characteristics, and has an excellent antihypertensive effect. Rosuvastatin is a blood lipid regulating drug and is suitable for primary hypercholesterolemia (IIa type, including heterozygous familial hypercholesterolemia) or hybrid dyslipidemia (IIb type) with dyslipidemia incapable of being properly controlled through diet control and other non-drug treatment (such as sports therapy and weight losing). The compound preparation is formed by olmesartan medoxomil and rosuvastatin and is more suitable for treating patients with cardiovascular diseases, and the compliance of the patients is improved.

The invention relates to a Chinese medicinal composition for treating lung cancer. The composition consists of an active ingredient or the active ingredient and a pharmaceutically acceptable carrier. The active ingredient is prepared from the following pharmaceutical ingredients: adenophora, asparagus root, dwarf lilyturf tuber, shizandra berry, American ginseng, unibract fritillary bulb, loquat leaves, barbed skullcap herb, astragalus, scorch-fried three immortals, powdered notoginseng root, arisaema cum bile, pinellia tuber, bamboo shavings, patrinia heterophylla Bge., bittersweet herb, common hongfennel root, Chinese paris rhizome and redroot gromwell root. The Chinese medicinal composition of the invention has the effect of clearing heat and resolving toxin, and eliminating blood stasis and detoxicating, is used for surgery and treatment after radiation treatment for lung cancer caused by accumulated toxin and blood-stasis obstruction, has no toxic or side effects, has an obvious treatment effect and a total effective rate of more than 95.0 percent, and is an ideal medicament for treating lung cancer.